colorectal cancer

Research in Review

Rare Form of Colorectal Cancer Responds Well to Precision Medicine

04/06/2017

JCP Editors

Patients with a specific type of metastatic colorectal cancer who are chemotherapy-resistant benefit from treatment with a gene-targeting regimen. ----- Related Content ESMO announces changes to metastatic...

...

04/06/2017

Journal of Clinical Pathways

Research in Review

Immune Checkpoint Inhibitor New Standard of Care for MSI-H Metastatic Colorectal Cancer

01/25/2017

JCP Editors

The immune checkpoint inhibitor nivolumab has shown durable responses and disease control in pretreated patients with DNA mismatch repair deficient/microsatellite instability high (MSI-H) metastatic colorectal...

The...

01/25/2017

Journal of Clinical Pathways

Research in Review

Insurance Expansion Improves Resection Rates Among Patients with Colorectal Cancer

12/13/2016

JCP Editors

The implementation of health care reform in Massachusetts increased surgical resection rates for colorectal cancer and decreased the likelihood of emergent resection, suggesting that insurance expansion may improve...

The...

12/13/2016

Journal of Clinical Pathways

Research in Review

Researchers Clarify Data for Epi proColon Used in USPSTF Guidelines

10/28/2016

JCP Editors

The recently published US Preventative Services Task Force (USPSTF) updated recommendation statement on colorectal cancer screening referenced multiple available options for colorectal screening, including...

The...

10/28/2016

Journal of Clinical Pathways

Department

Trial Shows Precision Medicine Improves Cancer Survival

09/28/2016

JCP Editors

Data from the Paris-based Molecular Screening for Cancer Treatment Optimization (MOSCATO) trial demonstrates that establishing molecular portraits improves survival for patients with advanced cancer by tailoring...

Data...

09/28/2016

Journal of Clinical Pathways

Department

Critical Considerations in Colorectal Pathway Development

09/19/2016

JCP Editors

In an early session at the Clinical Pathways Congress, Bert H O’Neil, MD, Indian University Simon Cancer Center (Indianapolis, IN) discussed some of the important factors to consider when developing a clinical...

In an...

09/19/2016

Journal of Clinical Pathways

Research in Review

Lymph Node Ratio an Effective Indicator of Prognosis in Rectal Cancer

06/20/2016

JCP Editors

Lymph node ratio (LNR) may be a significant indicator of prognosis in patients with rectal cancer and could be used to better stratify patients in clinical trials, claims a recently published...

Lymph...

06/20/2016

Journal of Clinical Pathways

Research in Review

Financial Strain Linked to More Pain and Poorer Quality of Life in Patients with Lung and Colorectal Cancers

03/06/2016

JCP Editors

Patients with cancer and limited financial means are more likely to have a higher symptom burden and decreased quality of life (QOL), according to a recent study. Rising health care costs mean that the treatments...

...

03/06/2016

Journal of Clinical Pathways

Research in Review

Clinical Pathways for Breast, Colon, and Rectal Cancers Improve Physician Adherence to Best Practices

02/16/2016

JCP Editors

Implementation of clinical pathways for breast, colon, and rectal cancers can help narrow the gap between evidence-based treatment guidelines and clinical practice, according to a new study.  With research on...

...

02/16/2016

Journal of Clinical Pathways

Research in Review

Bankruptcy Associated with Increased Mortality Risk for Patients with Cancer

01/29/2016

JCP Editors

A new study suggests that financial stress, rooted in filing for bankruptcy, may be a risk factor for increased mortality after a cancer diagnosis. Patients with cancer are more likely than the general population to...

A new...

01/29/2016

Journal of Clinical Pathways